We use cookies to improve your experience on this website. Read More Allow Cookies

Timeline of CCRC

  • Home Sweet Home

    Home Sweet Home

    CCRC begins the process of moving to a new purpose built centre in the Western Gateway Building in UCC to join other health research groups in a translational health campus.

  • Waiting to exhale

    Waiting to exhale

    The first patient is safely treated with our patented device for inoperable lung cancer changing the face of lung cancer treatment forever.

  • First Time

    First Time

    The Pancreatic Cancer Research Fund (UK) invests £1.2 million into seven ambitious projects to tackle the worlds deadliest cancer. For the first time one of these grants is awarded to an Irish Project, that of our Investigator Dr. Patrick Forde.

  • Hope grows

    Hope grows

    The Clinical trial for inoperable Colorectal cancer expands to three Irish hospitals and to Denmark.

  • Change Gang

    Change Gang

    CCRC researchers receive the 2013 Pfizer Innovation through team work for their device to treat inooperable lung cancer.

  • A promise for the future

    A promise for the future

    Dr. Mark Tangney's work using bacteria to deliver anti-cancer treatment is selected in 2012 by the prestigous journal, New Scientist, as one of the 5 most promising approaches to end cancer in the next 10 years.

  • A strong foundation

    A strong foundation

    Our founder Prof. Gerry O'Sullivan passed away in 2012 but left behind the legacy of a strong research vision and team. "He laid an incredibly strong foundation and on that foundation great things are being built." quote from Dr. Derek Power from Gerry O video.

  • Breakthrough

    Breakthrough

    Our charity Breakthrough Cancer Research is launched, allowing us to take our message of hope all around Ireland.

  • A Noble Pursuit

    A Noble Pursuit

    In 2010, while visiting our research labs, nobel prize winner James Watson says about the centre's Autophagy programme; "You’re ahead of us over here. This is incredible, I can't wait to tell them about this back home."

  • Lets talk treatment

    Lets talk treatment

    CCRC host the 10th Annual Meeting of the International Society for Cell and Gene Therapy of Cancer, bringing world class experts together to share their findings.

  • New Hope

    New Hope

    In 2009, CCRC receives IMB approval to commence clinical trial for treatment of inoperable colorectal tumours using their patented device for both drug and gene delivery.

  • PROSTATE CANCER VACCINE

    PROSTATE CANCER VACCINE

    A gene therapy approach is shown to reduce prostate tumour growth and is published by CCRC in Molecular Therapy.

  • EUROPE CALLING

    EUROPE CALLING

    Centre Director Prof. Gerald C. O'Sullivan commences Presidency of the European Surgical Association.

  • Profound Impact

    Profound Impact

    In recognition of his "profound impact on Irish, European, and American surgery", the American College of Surgeons confers an Honorary Fellowship on Centre Director Prof. Gerald C. O'Sullivan.

  • It's a first

    It's a first

    CCRC receives Irish Medicines Board's (IMB) approval to commence the first clinical trial in Ireland using gene delivery.

  • IMMUNOGENE THERAPY

    IMMUNOGENE THERAPY

    An immunogene therapy approach is shown to reduce both primary and secondary tumours and is published by CCRC in Cancer Gene Therapy.

  • In the Blood

    In the Blood

    CCRC publishes research on Leukemia in Blood - One of the Top 100 influential Biology and Medical Journals.

  • Elected

    Elected

    Centre Director Prof. Gerald C. O'Sullivan is elected President of the Royal College of Surgeons in Ireland.

  • CEFUS

    CEFUS

    CCRC commences a clinical trial using Combined Electric Field and Ultra Sound as a novel anti-tumour treatment.

  • Moving Up

    Moving Up

    CCRC moves into the state of the art Leslie C. Quick Jr. Laboratory, allowing a significant expansion in programmes and personnel.

  • High Alert

    High Alert

    CCRC commences a colorectal screening clinic, the first in Ireland, to screen high risk patients. The clinic also gives opportunity to research diet and lifestyle influences.

  • Under my skin

    Under my skin

    CCRC commences a clinical trial using Electrochemotherapy to treat inoperable skin based cancer. The combined EU study results show an 85% response rate to the treatment.

  • YOU ARE WHAT YOU EAT

    YOU ARE WHAT YOU EAT

    The Syncan Project Human Study at the CCRC finds that synbiotics reduce risk factors for colon cancer.

  • A NATURAL REACTION

    A NATURAL REACTION

    CCRC publishes on Immune Reactivity in Nature Medicine - the premier journal for biomedical research.

  • BEST DEFENCE

    BEST DEFENCE

    CCRC publishes on FAS Counterattack in Nature Medicine - the premier journal for biomedical research.

  • GENESIS

    GENESIS

    Cork Cancer Research Centre is founded by Professor Gerald C. O'Sullivan and UCC, supported by Atlantic Philanthropies and commences operation in labs in Mercy university Hospital Cork.